Almeda Ventures

About

Portfolio · 4

TailorMed

TailorMed provides an end-to-end solution that removes access, affordability, and adherence barriers across the medication journey, connecting patients to resources within the nation's largest and most diverse network.

2 rounds $60.0M committed Latest: 2024-11

BioProtect

Developer of biodegradable balloon implants designed to protect healthy tissue during radiation therapy for prostate cancer.

1 round $28.0M committed Latest: 2023-09

Surgical KIS

Surgical KIS is developing an innovative system, the SLEEK suture, to attach artificial valves to heart tissues more efficiently, quickly and precisely.

Led ★ 1 round $36.0M committed Latest: 2021-03

Nurami Medical

A biotechnology-driven company advancing innovation in soft-tissue repair, leveraging nanofibers and engineered biomaterials to transform patient recovery.

Led ★ 1 round $6.0M committed Latest: 2020-11

Q&A

What is Almeda Ventures' primary investment focus?

Almeda Ventures is a HealthTech-focused public R&D partnership that invests globally, concentrating on Medical devices, Digital health, and Bio-convergence.

What stages of investment does Almeda Ventures typically engage in?

Almeda Ventures invests across various stages including Pre-Seed, Seed, A Round, B Round, and C Round.

Where is Almeda Ventures headquartered?

Almeda Ventures is headquartered in Tel Aviv-Yafo, Israel.

When was Almeda Ventures founded?

Almeda Ventures was founded in 2020.

What is Almeda Ventures' investment strategy regarding company stage and capital use?

Almeda Ventures focuses on companies at the clinical stage after proof of concept and human trials, with capital earmarked for trials required for FDA approval and to initiate sales.

What kind of teams does Almeda Ventures seek to invest in?

Almeda Ventures seeks exceptional teams with innovative solutions addressing major unmet needs, supported by a proven clinical concept and a proven business model.